Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 28, 2016 |
| Target | IDT Australia - CMAX Clinical Trial Business |
| Sector | Life Science |
| Buyer(s) | I rom Group Co. |
| Sellers(s) | IDT Australia |
| Deal Type | Divestiture |
| Deal Value | 14M AUD |
FILTER BY
I'rom Group Co. Ltd. is a manufacturer of generic drugs in japan.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Australia | 1 of 1 |
| Year: 2016 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1975 |
| Sector | Medical Products |
| Revenue | 19M AUD (2025) |
IDT Australia is a pharmaceutical manufacturing company that develops and produces high-potency and high-containment pharmaceutical products for local and international clients. IDT Australia was founded in 1975 and is based in Boronia, Australia.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Australia | 1 of 1 |
| Year: 2016 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-01-01 |
IDT Australia - CMAX Clinical Trial Business
Boronia, Australia IDT Australia Ltd. - CMAX Clinical Trial Business offers a full suite of clinical trial services including Phase I clinical trials management and delivery, recruitment in specific disease states for Phase II and Phase III trials. |
Buy | - |
